Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mycosis Fungoides × duvelisib × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sezary Syndrome 1 Mycosis Fungoides 1

Interventions

Specimen Handling 3 Biopsy 3 Nivolumab 2 Magnetic Resonance Spectroscopy 2 talimogene laherparepvec 1 sodium-iodide symporter 1 mogamulizumab 1 fludarabine 1 duvelisib 1 cemiplimab 1 X-Rays 1 Phototherapy 1 Photons 1 MEDI-570 1 Ipilimumab 1 Immunoglobulin G 1 Disulfides 1 Cyclophosphamide 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04652960 2026-03-18

Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome

National Cancer Institute (NCI)

Phase 1 Active not recruiting

Mycosis Fungoides, Sezary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡